Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration

Abstract

This study examined the importance of aldosterone (ALDO) in mediating changes in renal function and increased mean arterial pressure (MAP) during the development of dietary-induced obesity in chronically instrumented dogs. Mean arterial pressure, heart rate (HR), and cardiac output (CO) were recorded 24 hours per day in lean dogs (n=7) before and after administration of an ALDO antagonist, eplerenone (EP) (10 mg/kg twice daily), for 10 days. After 10 days of EP treatment, the dogs (n=7) were given a supplement of cooked beef fat for 5 weeks while EP was continued. An untreated group (n=6) was fed a high fat diet for 5 weeks and used as control (C). In lean dogs, EP decreased MAP from 89±4 to 84±4 mm Hg and glomerular filtration rate from 67.4±6.8 to 53.2±4.9 mL/min while inducing a small negative Na+ balance (-42±12 mEq). Plasma renin activity increased from 0.4±+0.1 to 2.7±0.7 ng Al/mL per hour and plasma K + increased from 4.8±0.1 to 6.1±0.3 mEq/L. After 5 weeks of a high fat diet, body weight increased 45% to 53% in EP and C obese dogs. In C dogs, MAP increased by 16±3 mm Hg, compared with only 7±1 mm Hg in EPLE dogs. Compared with untreated dogs, the EP dogs had smaller increases in CO (18±4.6% versus 43±1.5%), HR (33±5% versus 60±3%), glomerular filtration rate (19±5% versus 38±6%), and cumulative Na+ balance (138±35 mEq versus 472±110 mEq) after 5 weeks of a high fat diet. Thus, EP markedly attenuated glomerular hyperfiltration, sodium retention, and hypertension associated with chronic dietary-induced obesity. These observations indicate that ALDO plays an important role in the pathogenesis of obesity hypertension.